FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
July 2, 2024 Comments Off
It’s a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial rejection from the FDA last year.
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
It’s a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial rejection from the FDA last year.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender